{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:07:45Z","timestamp":1779084465920,"version":"3.51.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Growing evidence suggests a mechanistic link between type 2 diabetes mellitus and Parkinson\u2019s disease (PD), with insulin-degrading enzyme (IDE) implicated in both insulin and amyloid-\u03b2 metabolism, as well as \u03b1-synuclein degradation. However, the role of IDE in PD pathogenesis remains insufficiently defined. This study aimed to investigate the association of\n                      <jats:italic>IDE<\/jats:italic>\n                      gene polymorphisms and serum IDE levels with sporadic PD in a Chinese Han population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fourteen single nucleotide polymorphisms (SNPs) within the\n                      <jats:italic>IDE<\/jats:italic>\n                      gene were genotyped in 463 patients with sporadic PD and 576 age- and sex-matched healthy controls (HCs). An independent cohort of 100 PD patients and 100 HCs was used to quantify serum IDE concentrations. Correlations between IDE levels and clinical features were assessed. Logistic regression was employed to identify independent factors associated with PD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the examined SNPs, rs11187007 showed a nominal allelic association with PD (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.046), which did not survive the Bonferroni correction. Serum IDE concentrations were significantly higher in PD patients than in HCs (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.015). Elevated IDE levels were negatively correlated with Mini-Mental State Examination scores (\n                      <jats:italic>R<\/jats:italic>\n                      = \u20130.230,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.027) and positively associated with more severe symptoms. Logistic regression indicated that elevated serum IDE levels were associated with PD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings highlight that elevated serum IDE correlates with PD, suggesting a role for IDE in neurodegeneration, warranting further mechanistic and longitudinal studies to evaluate its potential as a therapeutic target in PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2026.1827842","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:42:21Z","timestamp":1779082941000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic and clinical investigation of insulin-degrading enzyme in Parkinson\u2019s disease within the Chinese Han population"],"prefix":"10.3389","volume":"20","author":[{"given":"Huimin","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lue","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhe","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyuan","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"The Academy of Medical Sciences of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Henan Key Laboratory of Cerebrovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou","place":["Henan, China"]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences, School of Life Sciences, Zhengzhou University, Zhengzhou","place":["Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou","place":["Henan, China"]},{"name":"Department of Neurology, Beijing Tiantan Hospital, Headache Center, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/mds.29122","article-title":"The impact of Type 2 diabetes in Parkinson\u2019s disease.","volume":"37","author":"Athauda","year":"2022","journal-title":"Mov. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson\u2019s disease, insulin resistance and novel agents of neuroprotection.","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neurobiolaging.2004.07.011","article-title":"Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer\u2019s disease brain.","volume":"26","author":"Blomqvist","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10048-004-0173-4","article-title":"Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.","volume":"5","author":"Blomqvist","year":"2004","journal-title":"Neurogenetics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1326-3-22","article-title":"Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation.","volume":"3","author":"Bulloj","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"B6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/jad-2010-1206","article-title":"Insulin-degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid-beta degrading protease.","volume":"19","author":"Bulloj","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e8764","DOI":"10.1371\/journal.pone.0008764","article-title":"Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer\u2019s disease.","volume":"5","author":"Carrasquillo","year":"2010","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/jpd-191900","article-title":"The association between Type 2 diabetes mellitus and Parkinson\u2019s disease.","volume":"10","author":"Cheong","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","article-title":"Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo.","volume":"58","author":"Chiu","year":"2008","journal-title":"Neuron"},{"key":"B10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/1567205014666170203100734","article-title":"Change in INSR, APBA2 and IDE gene expressions in brains of Alzheimer\u2019s disease patients.","volume":"14","author":"da Costa","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4161\/pri.2.2.6710","article-title":"The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: A biological perspective.","volume":"2","author":"de Tullio","year":"2008","journal-title":"Prion"},{"key":"B12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations.","volume":"622","author":"Eldjarn","year":"2023","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results.","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.mcpro.2022.100452","article-title":"Mass spectrometry-based proteomics analysis of human substantia nigra from Parkinson\u2019s disease patients identifies multiple pathways potentially involved in the disease.","volume":"22","author":"Jang","year":"2023","journal-title":"Mol. Cell Proteom."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2944","DOI":"10.1002\/dmrr.2944","article-title":"High genetic risk scores for impaired insulin secretory capacity doubles the risk for type 2 diabetes in Asians and is exacerbated by Western-type diets.","volume":"34","author":"Kim","year":"2018","journal-title":"Diab. Metab. Res. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.1500877112","article-title":"Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.","volume":"112","author":"Kleinridders","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10522-015-9569-9","article-title":"Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.","volume":"16","author":"Kochkina","year":"2015","journal-title":"Biogerontology"},{"key":"B18","first-page":"199","article-title":"Correlation between insulin-degrading enzyme versus total tau and selected cytokines in patients with Alzheimer\u2019s disease compared to non-demented controls.","volume":"44","author":"Kullenberg","year":"2023","journal-title":"Neuro Endocrinol. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12020-022-03123-7","article-title":"Increased levels of insulin-degrading enzyme in patients with type 2 diabetes mellitus.","volume":"77","author":"Kullenberg","year":"2022","journal-title":"Endocrine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12020-023-03603-4","article-title":"Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer\u2019s disease, and healthy controls: A comparative study.","volume":"84","author":"Kullenberg","year":"2024","journal-title":"Endocrine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/bj20041081","article-title":"Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria.","volume":"383","author":"Leissring","year":"2004","journal-title":"Biochem. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/humu.20567","article-title":"Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease.","volume":"28","author":"Liang","year":"2007","journal-title":"Hum. Mutat."},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/jad-2011-111472","article-title":"Characterization of insulin degrading enzyme and other amyloid-\u03b2 degrading proteases in human serum: A role in Alzheimer\u2019s disease?","volume":"29","author":"Liu","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.molmed.2020.02.002","article-title":"Type 2 diabetes mellitus drugs for Alzheimer\u2019s disease: Current evidence and therapeutic opportunities.","volume":"26","author":"Meng","year":"2020","journal-title":"Trends Mol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00125-022-05729-y","article-title":"Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.","volume":"65","author":"Merino","year":"2022","journal-title":"Diabetologia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neurobiolaging.2006.03.009","article-title":"Weak independent association signals between IDE polymorphisms, Alzheimer\u2019s disease and cognitive measures.","volume":"28","author":"Mueller","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"970925","DOI":"10.3389\/fnins.2022.970925","article-title":"The neuroprotective effects of glucagon-like peptide 1 in Alzheimer\u2019s and Parkinson\u2019s disease: An in-depth review.","volume":"16","author":"Reich","year":"2022","journal-title":"Front. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"199.e113","DOI":"10.1016\/j.neurobiolaging.2010.07.005","article-title":"Association between variants in IDE-KIF11-HHEX and plasma amyloid \u03b2 levels.","volume":"33","author":"Reitz","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00109-009-0540-6","article-title":"Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.","volume":"87","author":"Rudovich","year":"2009","journal-title":"J. Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","article-title":"Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease.","volume":"147","author":"Rutledge","year":"2024","journal-title":"Acta Neuropathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1007\/s12035-023-03359-y","article-title":"Type 2 diabetes (T2DM) and Parkinson\u2019s Disease (PD): A mechanistic approach.","volume":"60","author":"Sabari","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajmg.b.20106","article-title":"No association between the insulin degrading enzyme gene and Alzheimer\u2019s disease in a Japanese population.","author":"Sakai","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e83940","DOI":"10.1371\/journal.pone.0083940","article-title":"Integrative network analysis unveils convergent molecular pathways in Parkinson\u2019s disease and diabetes.","volume":"8","author":"Santiago","year":"","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.molmed.2013.01.002","article-title":"Shared dysregulated pathways lead to Parkinson\u2019s disease and diabetes.","volume":"19","author":"Santiago","year":"","journal-title":"Trends Mol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: An updated proposal including opicapone and safinamide.","volume":"7","author":"Schade","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2015.09.002","article-title":"Insulin-degrading enzyme is activated by the C-terminus of \u03b1-synuclein.","volume":"466","author":"Sharma","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"12531","DOI":"10.1038\/srep12531","article-title":"Insulin-degrading enzyme prevents \u03b1-synuclein fibril formation in a nonproteolytical manner.","volume":"5","author":"Sharma","year":"","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/path.5777","article-title":"Insulin-degrading enzyme: An ally against metabolic and neurodegenerative diseases.","volume":"255","author":"Sousa","year":"2021","journal-title":"J. Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.2337\/db12-1045","article-title":"The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of \u03b1-synuclein levels in \u03b2-cells.","volume":"62","author":"Steneberg","year":"2013","journal-title":"Diabetes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: Modelling study of Global Burden of Disease Study 2021.","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"B42","doi-asserted-by":"publisher","first-page":"101999","DOI":"10.1016\/j.arr.2023.101999","article-title":"Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer\u2019s disease and diabetes.","volume":"90","author":"Tian","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/10409238.2017.1337707","article-title":"Multiple functions of insulin-degrading enzyme: A metabolic crosslight?","volume":"52","author":"Tundo","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/jmg.2006.048470","article-title":"Insulin-degrading enzyme is genetically associated with Alzheimer\u2019s disease in the Finnish population.","volume":"44","author":"Veps\u00e4l\u00e4inen","year":"2007","journal-title":"J. Med. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/s0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: A phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1014.e1","DOI":"10.1016\/j.neurobiolaging.2010.08.004","article-title":"Exploration of 16 candidate genes identifies the association of IDE with Alzheimer\u2019s disease in Han Chinese.","volume":"33","author":"Wang","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41419-025-08055-4","article-title":"Insulin-degrading enzyme confers neuroprotection in Parkinson\u2019s disease by inhibiting the Hippo signaling pathway.","volume":"16","author":"Zheng","year":"2025","journal-title":"Cell Death Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/jhg.2010.117","article-title":"Variations in\/nearby genes coding for JAZF1, TSPAN8\/LGR5 and HHEX-IDE and risk of type 2 diabetes in Han Chinese.","volume":"55","author":"Zhou","year":"2010","journal-title":"J. Hum. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1212\/WNL.0b013e3181d07654","article-title":"Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease.","volume":"74","author":"Zou","year":"2010","journal-title":"Neurology"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1827842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:42:22Z","timestamp":1779082942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1827842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":49,"alternative-id":["10.3389\/fnins.2026.1827842"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1827842","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1827842"}}